Abciximab (ReoPro) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis

Clinical trial NCT01932554 · WITHDRAWN

Trial details

NCT number: NCT01932554
Sponsor: St. Louis University
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease Hb-SS Disease With Vasoocclusive Pain Hemoglobin SS Disease With Vasoocclusive Crisis Other Sickle Cell Disease With Vaso-Occlusive Pain Hemoglobin SS Disease With Crisis

Start date: 2013-11-01
Primary completion: 2015-03-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.